195 related articles for article (PubMed ID: 28832537)
1. High Boron-loaded DNA-Oligomers as Potential Boron Neutron Capture Therapy and Antisense Oligonucleotide Dual-Action Anticancer Agents.
Kaniowski D; Ebenryter-Olbińska K; Sobczak M; Wojtczak B; Janczak S; Leśnikowski ZJ; Nawrot B
Molecules; 2017 Aug; 22(9):. PubMed ID: 28832537
[TBL] [Abstract][Full Text] [Related]
2. Versatile Method for the Site-Specific Modification of DNA with Boron Clusters: Anti-Epidermal Growth Factor Receptor (EGFR) Antisense Oligonucleotide Case.
Ebenryter-Olbińska K; Kaniowski D; Sobczak M; Wojtczak BA; Janczak S; Wielgus E; Nawrot B; Leśnikowski ZJ
Chemistry; 2017 Nov; 23(65):16535-16546. PubMed ID: 28881435
[TBL] [Abstract][Full Text] [Related]
3. Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides.
Kaniowski D; Kulik K; Suwara J; Ebenryter-Olbińska K; Nawrot B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293047
[TBL] [Abstract][Full Text] [Related]
4. Composites of Nucleic Acids and Boron Clusters (C
Kaniowski D; Ebenryter-Olbińska K; Kulik K; Suwara J; Cypryk W; Jakóbik-Kolon A; Leśnikowski Z; Nawrot B
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064412
[TBL] [Abstract][Full Text] [Related]
5. Metallacarborane Complex Boosts the Rate of DNA Oligonucleotide Hydrolysis in the Reaction Catalyzed by Snake Venom Phosphodiesterase.
Kaniowski D; Kulik K; Ebenryter-Olbińska K; Wielgus E; Leśnikowski Z; Nawrot B
Biomolecules; 2020 May; 10(5):. PubMed ID: 32380792
[TBL] [Abstract][Full Text] [Related]
6. EGFR-Targeted Cellular Delivery of Therapeutic Nucleic Acids Mediated by Boron Clusters.
Kaniowski D; Suwara J; Ebenryter-Olbińska K; Jakóbik-Kolon A; Nawrot B
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499115
[TBL] [Abstract][Full Text] [Related]
7. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy.
Nizioł J; Uram Ł; Szuster M; Sekuła J; Ruman T
Bioorg Med Chem; 2015 Oct; 23(19):6297-304. PubMed ID: 26344594
[TBL] [Abstract][Full Text] [Related]
9. Carboranyl oligonucleotides: 4. synthesis and physicochemical studies of oligonucleotides containing 2'-O-(o-carboran-1-yl)methyl group.
Olejniczak AB; Koziolkiewicz M; Lesnikowski ZJ
Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):79-94. PubMed ID: 12074368
[TBL] [Abstract][Full Text] [Related]
10. Terminal Mono- and Bis-Conjugates of Oligonucleotides with
Novopashina DS; Vorobyeva MA; Lomzov AA; Silnikov VN; Venyaminova AG
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375375
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
Cai J; Hosmane NS; Takagaki M; Zhu Y
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066470
[TBL] [Abstract][Full Text] [Related]
13. [Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy].
Nakamura H
Yakugaku Zasshi; 2013; 133(12):1297-306. PubMed ID: 24292174
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G
Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing using a conjugate comprising Tat peptide and antisense oligonucleotide with phosphorothioate backbones.
Maegawa Y; Mochizuki S; Miyamoto N; Sakurai K
Bioorg Med Chem Lett; 2016 Feb; 26(4):1276-8. PubMed ID: 26774656
[TBL] [Abstract][Full Text] [Related]
17. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
[TBL] [Abstract][Full Text] [Related]
19. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
[TBL] [Abstract][Full Text] [Related]
20. Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation.
El-Zaria ME; Ban HS; Nakamura H
Chemistry; 2010 Feb; 16(5):1543-52. PubMed ID: 20020518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
